Human Edge is a technology company.
Human Edge has raised $2.0M across 1 funding round.
Human Edge has raised $2.0M in total across 1 funding round.
Human Edge has raised $2.0M in total across 1 funding round.
Human Edge's investors include Bharat Innovation Fund.
Human Edge is an enterprise healthtech and longevity science company that develops personalized solutions to optimize the health, wellbeing, and performance of senior executives and global workforces.[1][2] Its flagship products include Ever™, a 100-day personalized longevity program with concierge guidance from medical experts and coaches, and the Mito™ app, which integrates wearable data, blood biomarkers, and digital biomarkers for dynamic health monitoring and customized interventions.[2] The company serves time-starved executives and corporations, addressing age-related health challenges, energy optimization, and work-life balance through science-backed biohacking, supplements, and community support—claiming impact on over 55,000 individuals via corporate clients.[1][2] This shifts from reactive sick care to proactive healthcare, fostering peak performance and health equity.[1][2]
Human Edge was founded on November 23, 2020, in Mumbai, India, by a physician championing lifestyle interventions and digital biomarkers to "hack the human operating system" for extended healthspan.[1][2] The founder, with experience in medical and wellness fields including roles at the Royal Air Force and NASA's Kennedy Space Center, launched the investor-backed venture to help individuals—especially executives—achieve their best health amid workplace challenges.[1][2] Early traction came through accelerator participation like Firefly Innovations, where it positioned as an enterprise-first longevity platform using proprietary biohacks from wearables and expert data streams.[1] Pivotal moments include developing Ever™ and Mito™, which enabled rapid scaling to serve global corporate clients.[2]
(Note: Search results distinguish this from unrelated U.S.-based staffing firms like HumanEdge, which focus on recruitment.[3][4])
Human Edge rides the longevity tech and corporate wellness boom, capitalizing on rising demand for personalized health amid workforce burnout, aging executives, and post-pandemic health equity focus.[1][2] Timing aligns with wearable proliferation (e.g., FitBit, CGM) and AI-driven biomarkers, enabling scalable biohacking in a $4.5T global wellness market projected to grow via enterprise adoption.[1][2] Market forces like escalating healthcare costs and productivity losses from health disparities favor its proactive model, influencing ecosystems by partnering with corporations to normalize longevity science—potentially setting standards for "durable, high-performing" workforces.[1][2]
Human Edge is poised to expand Ever™ and Mito™ globally, targeting more enterprise clients with AI-enhanced personalization as biomarker tech advances.[2] Trends like integrated wearables, preventive biotech, and hybrid work will amplify its role, evolving from executive-focused to workforce-wide platforms—potentially partnering with insurers or HR giants. As longevity science matures, its influence could redefine corporate health cultures, turning peak performance into a scalable standard and solidifying its edge in healthtech.
Human Edge has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in August 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2022 | $2.0M Seed | Bharat Innovation Fund |